New £1 million funding from the Defence Science and Technology Laboratory (Dstl) is available for innovative diagnostics that identify and can help treat people exposed to biological and chemical weapons within one hour.
Exposure to biological or chemical agents still represents a key issue for deployed personnel. Outputs from this competition that rapidly detect agents and enable quicker treatment will help improve UK capability to manage and treat personnel affected by virulent infectious agents or toxic chemicals.
Current technologies that enable diagnosis of individuals exposed to biological or chemical agents are time-consuming, resource intensive and can only provide limited identification capability. They often rely on laboratory facilities, where sufficient infrastructure and expertise are available to interpret complex data. This themed competition seeks to address current limitations of diagnostic technologies through the development of novel, enhanced point of care diagnostic devices, which provide a result in approximately 1 hour. The technology should also be able to be used in proximity to the patient, and in demanding austere locations.
Improved point of care solutions will enable clinicians to make informed, high confidence, diagnoses that optimise the management of affected individuals.
The deadline for submitting a proposal is midday (BST) 22 September 2022.
Further info and how to apply for funding can be found here.